GERON CORP — Director's Dealing 2023

Sep 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2023-08-15

Reporting Person: Bloom Olivia Kyusuk (EVP, Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-15	Employee Stock Option (right to buy)	$1.72	A	250000	Acquired	2028-11-06	Common Stock (250000)	Direct

Footnotes

F1: Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the
US FDA for imetelstat in lower risk MDS.